Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45
Purified protein vaccines often require adjuvants for efficient stimulation of immune responses. There is no licensed mucosal adjuvant on the market to adequately boost the immune response to purified antigens for intranasal applications in humans. Bacterial outer membrane vesicles (OMV) are attract...
Saved in:
Main Authors: | Michael Pritsch, Najib Ben-Khaled, Michael Chaloupka, Sebastian Kobold, Nicole Berens-Riha, Annabell Peter, Gabriele Liegl, Sören Schubert, Michael Hoelscher, Thomas Löscher, Andreas Wieser |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/3576028 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microphase Separation of a PS-b-PFS Block Copolymer via Solvent Annealing: Effect of Solvent, Substrate, and Exposure Time on Morphology
by: Colm T. O’Mahony, et al.
Published: (2015-01-01) -
Cerenkov Luminescence Tomography of Aminopeptidase N (APN/CD13) Expression in Mice Bearing HT1080 Tumors
by: Zhenhua Hu, et al.
Published: (2013-05-01) -
Congenital Intranasal Glioma
by: Sajad Ahmad Salati, et al.
Published: (2011-01-01) -
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma
by: Lucia Y. Chen, et al.
Published: (2025-01-01) -
Physical layer security performance of MF relay selection systems
by: Ying CHENG, et al.
Published: (2021-09-01)